ArticleFrontiers in digital health2026
HyperTransFusion: a hypernetwork transformer with black winged kite optimization for multimodal early Alzheimer's disease diagnosis.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early detection of Alzheimer's disease (AD) is critical for timely intervention and effective disease management. Existing diagnostic systems are often limited by unimodal data or static fusion strategies that fail to capture complex interactions between neuroimaging and cognitive biomarkers. Methods: A HyperTransFusion framework was proposed for AD classification using MRI scans and cognitive assessment scores from the ADNI dataset. The framework integrates a Hypernetwork-based Transformer for adaptive multimodal fusion, a Vision Transformer (ViT) for MRI feature extraction, dense embedding layers for cognitive features, and a BWKO-SA optimization strategy combining Black-Winged Kite Optimization and Simulated Annealing for hyperparameter tuning. Performance was evaluated using five-fold patient-wise cross-validation. Results: The proposed framework achieved a macro AUC of 0.9311 ± 0.039 and an overall accuracy of 0.8624 (95% CI: 0.7691-0.9558), demonstrating robust generalization across unseen subjects. Ablation studies confirmed the contribution of the Hypernetwork and BWKO-SA modules. Slice-level evaluation achieved a peak accuracy of 99.1%, reported only as a supplementary indicator of feature separability. Discussion: The proposed HyperTransFusion framework enables adaptive multimodal integration and improves the accuracy of early AD classification. Further validation using independent multi-center cohorts is required before clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.